|
Events
Healthcare Takeaways from 2015’s Consumer Electronics Show
Las Vegas’s CES (the International Consumer Electronics Show) is the largest trade show in a town known for hosting the world’s largest trade shows. Pharm Exec Editorial Advisory Board member Bill Drummy was there this month and highlights for us the must-have technology showcased at the event’s Digital Health Summit ...Read more
learn more about how to leverage Data and Analytics to enhance Copay Program Performance with this White Paper and Case Study.  Read more
Leadership
Pharm Exec’s 2015 Emerging Pharma Leaders — Nominate Now
Pharm Exec is looking for the fresh faces of pharma leadership, and we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2015 Emerging Pharma Leaders. Read more for details of how to nominate a colleague — or yourself. The deadline for this year’s entries is April 15 ...Read more
Regulatory
Massive House "Cures" Proposal Faces Tough Road Ahead
The “discussion draft” for legislation to speed “21st Century Cures” to patients emerged very quietly on Capitol Hill this week, muted by an absence of bipartisan support which had generated considerable enthusiasm for this effort to promote biomedical research and streamline regulation. Jill Wechsler reports
...Read more
Europe
The EC’s New Competition Commissioner: Implications for Pharma?
In theory, the personalities of EC commissioners should have little influence over the way they conduct the business they are charged with. But the very nature of competition law can lend itself to subjective judgements. So, asks Reflector, what attitude will the new European commissioner for competition, Margrethe Vestager, adopt toward the pharma industry?
...Read more
Forecast
What’s Ahead? Pharm Exec’s 2015 Industry Forecast
Following a year where a phenomenal cure was met by pricing outrage, the march of new products and promising immunotherapy cancer combos will continue in 2015. As pharma and tech jell, how will the industry live up to its value supposition while pricing and profiting in the developed and developing worlds? ...Read more
|
